Discussing patient suicides following forced tapering with the investigators of CSI: OPIOIDs

CSI:OPIOIDs (Clinical Context of Suicide Following Opioid Transitions) is a scientific research study to closely examine suicides that have occurred after prescription opioid dose reductions in patients with long-term pain. The team will look at 110-120 suicides, split between those individuals who were Veterans of the US armed forces and people who were not Veterans. The CSI:OPIOIDs team will: Compile a registry of people who have died by suicide following a reduction or stoppage in their opioid medication. Perform in-depth, one on one interviews with survivors of individuals who have died by suicide after opioid transition to understand what led their loved-one to die by suicide, and review medical records when they are obtainable. Identify factors common to these individuals prior to their death and suggest ways to reduce likelihood that future patients will die by suicide under similar circumstances. The approach used in this study, psychological autopsy, offers a descriptive portrait of each death. The resulting insights will help health systems, policy makers, and prescribers make better decisions to prevent these tragedies. There is a website for the general public and a separate one for persons who wish to enter the study. To learn more about the study or if you are interested in participating, please select the following: https://www.csiopioids.org/. #Stefan #Kertesz #patient #suicide #opioid #tapering